RxDoctor Payments DataLook up a doctor →

Lynn Kocian, PA

Physician Assistant · Gretna, NENPI 1386631026

Payments from drug & device makers

$11,623in general payments, 2019–2025

Across 864 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • Novo Nordisk$927
  • Amgen$734
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$415
  • plus $5K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)221$2,633
AstraZeneca33$1,239
Lilly USA, LLC107$1,010
Novo Nordisk101$927
Amgen48$734
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$415
Aimmune Therapeutics, Inc.7$360
Antares Pharma, Inc.35$357
Mayne Pharma Commercial LLC25$260
Biohaven Pharmaceuticals, Inc.21$240
Esperion Therapeutics, Inc.20$229
Pfizer13$226
Takeda Pharmaceuticals U.S.A., Inc.12$212
Abbott7$159
Bayer9$156
Amarin Pharma, Inc.12$146
Axsome Therapeutics, Inc.9$143
Lundbeck LLC7$143
Boehringer Ingelheim9$140
Biohaven Pharmaceutical Holding Company Ltd.17$129
Otsuka America Pharmaceutical, Inc.6$115
Vanda Pharmaceuticals Inc.4$95
GSK7$94
Arbor Pharmaceuticals, Inc.5$91
Merck5$80
Novartis4$77
Astellas Pharma US Inc4$73
Paratek Pharmaceuticals, Inc.5$72
Mannkind Corporation3$69
Jazz Pharmaceuticals Inc.4$61
Phathom Pharmaceuticals, Inc.8$57
Kowa Pharmaceuticals America, Inc.4$57
Vistapharm, Inc.3$54
Sanofi-aventis U.S. LLC3$51
Madrigal Pharmaceuticals2$46
Idorsia Pharmaceuticals US Inc3$43
Johnson & Johnson3$43
Actelion Pharmaceuticals US, Inc.2$42
Impel Pharmaceuticals Inc.2$41
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$38
Exeltis, USA Inc.2$38
Teva Pharmaceuticals USA, Inc.2$37
Smith+Nephew2$36
E.r. Squibb & Sons, L.L.C.2$34
Acella Pharmaceuticals, LLC2$34
Tolmar, Inc.2$34
Inspire Medical Systems, Inc.1$30
Currax Pharmaceuticals LLC2$27
Tris Pharma Inc1$23
Hologic Sales And Service, LLC1$22
Nestle Healthcare Nutrition Inc.1$20
Genentech USA, Inc.1$19
Ardelyx, Inc.1$18
Amneal Pharmaceuticals LLC1$18
Tactile Systems Technology Inc1$17
Mylan Specialty L.p.1$17
Ultragenyx Pharmaceutical Inc.1$15
Forte Bio-pharma LLC1$14
Ascensia Diabetes Care US Inc.1$13

How this compares

$11,623 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska →

Medicare billing

Part B allowed, 2024
$25,260
Medicare patients
120
Services billed
1,133

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Gretna

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →